These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 23979840

  • 1. Expression of asialoglycoprotein receptor 1 in human hepatocellular carcinoma.
    Shi B, Abrams M, Sepp-Lorenzino L.
    J Histochem Cytochem; 2013 Dec; 61(12):901-9. PubMed ID: 23979840
    [Abstract] [Full Text] [Related]

  • 2. Galactose Derivative-Modified Nanoparticles for Efficient siRNA Delivery to Hepatocellular Carcinoma.
    Huang KW, Lai YT, Chern GJ, Huang SF, Tsai CL, Sung YC, Chiang CC, Hwang PB, Ho TL, Huang RL, Shiue TY, Chen Y, Wang SK.
    Biomacromolecules; 2018 Jun 11; 19(6):2330-2339. PubMed ID: 29808997
    [Abstract] [Full Text] [Related]

  • 3. Improved method increases sensitivity for circulating hepatocellular carcinoma cells.
    Liu HY, Qian HH, Zhang XF, Li J, Yang X, Sun B, Ma JY, Chen L, Yin ZF.
    World J Gastroenterol; 2015 Mar 14; 21(10):2918-25. PubMed ID: 25780289
    [Abstract] [Full Text] [Related]

  • 4. Asialoglycoprotein receptor targeted delivery of doxorubicin nanoparticles for hepatocellular carcinoma.
    Pranatharthiharan S, Patel MD, Malshe VC, Pujari V, Gorakshakar A, Madkaikar M, Ghosh K, Devarajan PV.
    Drug Deliv; 2017 Nov 14; 24(1):20-29. PubMed ID: 28155331
    [Abstract] [Full Text] [Related]

  • 5. Detection of circulating tumor cells in hepatocellular carcinoma using antibodies against asialoglycoprotein receptor, carbamoyl phosphate synthetase 1 and pan-cytokeratin.
    Li J, Chen L, Zhang X, Zhang Y, Liu H, Sun B, Zhao L, Ge N, Qian H, Yang Y, Wu M, Yin Z.
    PLoS One; 2014 Nov 14; 9(4):e96185. PubMed ID: 24763545
    [Abstract] [Full Text] [Related]

  • 6. Asialoglycoprotein receptor targeted micelles containing carborane clusters for effective boron neutron capture therapy of hepatocellular carcinoma.
    Zhang T, Li G, Li S, Wang Z, He D, Wang Y, Zhang J, Li J, Bai Z, Zhang Q, Liu B, Zhao Q, Liu Y, Zhang H.
    Colloids Surf B Biointerfaces; 2019 Oct 01; 182():110397. PubMed ID: 31357127
    [Abstract] [Full Text] [Related]

  • 7. A novel multimarker assay for the phenotypic profiling of circulating tumor cells in hepatocellular carcinoma.
    Court CM, Hou S, Winograd P, Segel NH, Li QW, Zhu Y, Sadeghi S, Finn RS, Ganapathy E, Song M, French SW, Naini BV, Sho S, Kaldas FM, Busuttil RW, Tomlinson JS, Tseng HR, Agopian VG.
    Liver Transpl; 2018 Jul 01; 24(7):946-960. PubMed ID: 29624843
    [Abstract] [Full Text] [Related]

  • 8. Cancer-associated circulating large extracellular vesicles in cholangiocarcinoma and hepatocellular carcinoma.
    Julich-Haertel H, Urban SK, Krawczyk M, Willms A, Jankowski K, Patkowski W, Kruk B, Krasnodębski M, Ligocka J, Schwab R, Richardsen I, Schaaf S, Klein A, Gehlert S, Sänger H, Casper M, Banales JM, Schuppan D, Milkiewicz P, Lammert F, Krawczyk M, Lukacs-Kornek V, Kornek M.
    J Hepatol; 2017 Aug 01; 67(2):282-292. PubMed ID: 28267620
    [Abstract] [Full Text] [Related]

  • 9. New Small-Molecule Glycoconjugates of Docetaxel and GalNAc for Targeted Delivery to Hepatocellular Carcinoma.
    Petrov RA, Mefedova SR, Yamansarov EY, Maklakova SY, Grishin DA, Lopatukhina EV, Burenina OY, Lopukhov AV, Kovalev SV, Timchenko YV, Ondar EE, Ivanenkov YA, Evteev SA, Vaneev AN, Timoshenko RV, Klyachko NL, Erofeev AS, Gorelkin PV, Beloglazkina EK, Majouga AG.
    Mol Pharm; 2021 Jan 04; 18(1):461-468. PubMed ID: 33264010
    [Abstract] [Full Text] [Related]

  • 10. Hepatitis B virus (HBV) receptors: Deficiency in tumor results in scant HBV infection and overexpression in peritumor leads to higher recurrence risk.
    Jing YY, Liu WT, Guo SW, Ye F, Fan QM, Yu GF, Yu DD, Gao L, Sun K, Han ZP, Li R, Yang Y, Zhao QD, Wu MC, Wang HY, Wei LX.
    Oncotarget; 2015 Dec 15; 6(40):42952-62. PubMed ID: 26515593
    [Abstract] [Full Text] [Related]

  • 11. Design, synthesis and biological evaluation of the positional isomers of the galactose conjugates able to target hepatocellular carcinoma cells via ASGPR-mediated cellular uptake and cytotoxicity.
    Ye W, Tang Q, Zhou T, Zhou C, Fan C, Wang X, Wang C, Zhang K, Liao G, Zhou W.
    Eur J Med Chem; 2024 Jan 15; 264():115988. PubMed ID: 38039790
    [Abstract] [Full Text] [Related]

  • 12. A Dual-Targeting Functionalized Graphene Film for Rapid and Highly Sensitive Fluorescence Imaging Detection of Hepatocellular Carcinoma Circulating Tumor Cells.
    Wu C, Li P, Fan N, Han J, Zhang W, Zhang W, Tang B.
    ACS Appl Mater Interfaces; 2019 Dec 04; 11(48):44999-45006. PubMed ID: 31714050
    [Abstract] [Full Text] [Related]

  • 13. PDA-Based Glyconanomicelles for Hepatocellular Carcinoma Cells Active Targeting Via Mannose and Asialoglycoprotein Receptors.
    Negrete M, Romero-Ben E, Gutiérrez-Valencia A, Rosales-Barrios C, Alés E, Mena-Barragán T, Flores JA, Castillejos MC, de la Cruz-Ojeda P, Navarro-Villarán E, Cepeda-Franco C, Khiar N, Muntané J.
    ACS Appl Bio Mater; 2021 Jun 21; 4(6):4789-4799. PubMed ID: 35007028
    [Abstract] [Full Text] [Related]

  • 14. Targeted delivery of macromolecular drugs: asialoglycoprotein receptor (ASGPR) expression by selected hepatoma cell lines used in antiviral drug development.
    Li Y, Huang G, Diakur J, Wiebe LI.
    Curr Drug Deliv; 2008 Oct 21; 5(4):299-302. PubMed ID: 18855599
    [Abstract] [Full Text] [Related]

  • 15. Flow cytometric analysis of asialoglycoprotein receptor expression predicts hepatic functional reserve after hepatectomy.
    Ke Z, Li J, Zhe J, Liang LB, Yan L, Yi M.
    J Coll Physicians Surg Pak; 2014 Nov 21; 24(11):820-4. PubMed ID: 25404440
    [Abstract] [Full Text] [Related]

  • 16. Physiological roles of asialoglycoprotein receptors (ASGPRs) variants and recent advances in hepatic-targeted delivery of therapeutic molecules via ASGPRs.
    Hu J, Liu J, Yang D, Lu M, Yin J.
    Protein Pept Lett; 2014 Nov 21; 21(10):1025-30. PubMed ID: 24975671
    [Abstract] [Full Text] [Related]

  • 17. Cooperative Role of Thrombopoietin and Vascular Endothelial Growth Factor-A in the Progression of Liver Cirrhosis to Hepatocellular Carcinoma.
    Vizio B, Bosco O, David E, Caviglia GP, Abate ML, Schiavello M, Pucci A, Smedile A, Paraluppi G, Romagnoli R, Lupia E, Bellone G, Montrucchio G.
    Int J Mol Sci; 2021 Feb 12; 22(4):. PubMed ID: 33673041
    [Abstract] [Full Text] [Related]

  • 18. The asialoglycoprotein receptor in human hepatocellular carcinomas: its expression on proliferating cells.
    Trerè D, Fiume L, De Giorgi LB, Di Stefano G, Migaldi M, Derenzini M.
    Br J Cancer; 1999 Oct 12; 81(3):404-8. PubMed ID: 10507763
    [Abstract] [Full Text] [Related]

  • 19. Recent Advances in Asialoglycoprotein Receptor and Glycyrrhetinic Acid Receptor-Mediated and/or pH-Responsive Hepatocellular Carcinoma- Targeted Drug Delivery.
    Li YL, Zhu XM, Liang H, Orvig C, Chen ZF.
    Curr Med Chem; 2021 Oct 12; 28(8):1508-1534. PubMed ID: 32368967
    [Abstract] [Full Text] [Related]

  • 20. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
    Wang G, Chen JH, Qiang Y, Wang DZ, Chen Z.
    World J Gastroenterol; 2015 Apr 07; 21(13):3983-93. PubMed ID: 25852285
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.